Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases.
Treatment of cutaneous leishmaniasis is sometimes difficult. No single ideal therapy has yet been identified and some of the drugs that are currently used are associated with significant toxicity. We present two cases of cutaneous leishmaniasis in children, one caused by Leishmania infantum and the other by Leishmania braziliensis. Both of them were successfully treated with intravenous liposomal amphotericin B.
del Rosal
Teresa
T
Hospital La Paz, Department of Pediatric Infectious Diseases, Madrid, Spain. teredelrosal@yahoo.es
Artigao
Fernando Baquero
FB
Miguel
Maria J Garcia
MJ
de Lucas
Raul
R
del Castillo
Fernando
F
D000666:Amphotericin B / Q000008:administration & dosage*; D000981:Antiprotozoal Agents / Q000008:administration & dosage*; D002648:Child; D006801:Humans; D007223:Infant; D007892:Leishmania braziliensis / Q000187:drug effects*; D018314:Leishmania infantum / Q000187:drug effects*; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy* / Q000469:parasitology / Q000473:pathology; D008081:Liposomes; D008297:Male; D016133:Polymerase Chain Reaction; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D008081:Liposomes; D000666:Amphotericin B